Important considerations before combining these medications include: Absolute contraindications : The combination should be avoided in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, during or within 14 days of MAOI use, personal/family history of MTC or MEN2, pregnancy, breastfeeding, or severe gastrointestinal disease Cardiovascular risk assessment : Phentermine increases heart rate and blood pressure, which requires careful monitoring with baseline and follow-up measurements of vital signs and possibly EKG if cardiac history exists Gastrointestinal tolerability : Tirzepatide commonly causes nausea, vomiting, and diarrhea, which may be compounded by phentermine's effects Medication interactions : Tirzepatide may reduce the effectiveness of oral contraceptives during initiation and dose escalation

Drug distribution on the ADCs is a critical parameter as DAR0 species are by definition subpotent and can even block binding sites on the tumor cells from other higher DAR species leading to reduced efficacy
Secure transactions: Even if a peptide vendor is legitimate, unencrypted information may be stolen by third parties
Autoimmune disorders affect millions and can strike any organ